冠状动脉CT血管成像检测的特征预测非罪犯病变的斑块进展
该单中心试验分析103例因罪犯病变行CCTA和PCI的患者,12个月后复查CCTA并随访3年,34例(33%)出现非罪犯病变斑块进展;进展与ST段抬高型心肌梗死史、随访LDL-C水平、基线低衰减斑块及心外膜脂肪体积相关,且与后续MACE显著相关(log-rank P=0.006)。
要点
- 基线CCTA低衰减斑块与随访LDL-C水平独立预测非罪犯病变斑块进展。
- 非罪犯病变斑块进展与PCI后第二次CCTA之后的MACE显著相关(log-rank P=0.006)。
- CCTA无创评估非罪犯病变可能具有预后价值,原文表述为「has potential prognostic value」。
核心结论
- CCTA对非罪犯病变的无创评估可能具有预后价值。
- 非罪犯病变斑块进展与第二次CCTA后发生的MACE显著相关(log-rank P=0.006)。
研究设计与样本
- 单中心试验,分析103例连续接受CCTA和经皮冠状动脉介入治疗(PCI)的罪犯病变患者。
- 随访CCTA安排在PCI后12个月,所有患者在第二次CCTA检查后随访3年。
- 通过CCTA评估高危斑块特征和心外膜脂肪(EAT)体积,肉眼比较两次CCTA的狭窄级别以判定斑块进展。
关键影像表现/征象
- 高危斑块特征和心外膜脂肪体积通过CCTA评估。
- 基线低衰减斑块与非罪犯病变斑块进展独立相关(OR=7.311,95%CI=1.242-43.028,P=0.028)。
- 心外膜脂肪体积与非罪犯病变斑块进展独立相关(OR=1.015,95%CI=1.000-1.029,P=0.044)。
诊断标准与关键数值
- 斑块进展定义为两次CCTA间非罪犯病变狭窄级别肉眼比较出现变化。
- 非罪犯病变斑块进展的独立相关因素:ST段抬高型心肌梗死史(OR=5.855,95%CI=1.391-24.635,P=0.016)。
- 非罪犯病变斑块进展的独立相关因素:随访低密度脂蛋白胆固醇水平(OR=6.832,95%CI=2.103-22.200,P=0.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
- 研究结论认为CCTA对非罪犯病变的无创评估可能具有预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study sought to determine whether variables detected on coronary computed tomography angiography (CCTA) would predict plaque progression in non-culprit lesions (NCL).
MATERIALS AND METHODS: In this single-center trial, we analyzed 103 consecutive patients who were undergoing CCTA and percutaneous coronary intervention (PCI) for culprit lesions. Follow-up CCTA was scheduled 12 months after the PCI, and all patients were followed for 3 years after their second CCTA examination. High-risk plaque features and epicardial adipose tissue (EAT) volume were assessed by CCTA. Each NCL stenosis grade was compared visually between two CCTA scans to detect plaque progression, and patients were stratified into two groups based on this. Logistic regression analysis was used to evaluate the factors that were independently associated with plaque progression in NCLs. Time-to-event curves were compared using the log-rank statistic.
RESULTS: Overall, 34 of 103 patients exhibited NCL plaque progression (33%). Logistic regression analyses showed that the NCL progression was associated with a history of ST-elevated myocardial infarction (odds ratio [OR] = 5.855, 95% confidence interval [CI] = 1.391-24.635, p = 0.016), follow-up low-density lipoprotein cholesterol level (OR = 6.832, 95% CI = 2.103-22.200, p = 0.001), baseline low-attenuation plaque (OR = 7.311, 95% CI = 1.242-43.028, p = 0.028) and EAT (OR = 1.015, 95% CI = 1.000-1.029, p = 0.044). Following the second CCTA examination, major adverse cardiac events (MACEs) were observed in 12 patients, and NCL plaque progression was significantly associated with future MACEs (log rank p = 0.006).
CONCLUSION: Noninvasive assessment of NCLs by CCTA has potential prognostic value.
引用
- Tan Y, Zhou J, Zhou Y, et al. Characteristics Detected on Computed Tomography Angiography Predict Coronary Artery Plaque Progression in Non-Culprit Lesions. Korean J Radiol. 2017. PMID: 28458601. doi:10.3348/kjr.2017.18.3.487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。